AI assistant
AMICUS THERAPEUTICS, INC. — Director's Dealing 2020
Jun 3, 2020
31523_dirs_2020-06-03_8899d2f7-8dba-431a-9c43-3e3b7a0736e6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AMICUS THERAPEUTICS, INC. (FOLD)
CIK: 0001178879
Period of Report: 2020-06-01
Reporting Person: Crowley John F (Director, Chairman & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-05-26 | Common Stock | G | 30000 | $0.00 | Disposed | 909941 | Direct |
| 2020-06-01 | Common Stock | S | 9755 | $12.6553 | Disposed | 900186 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 64895 | Indirect |
Footnotes
F1: The gift of shares reported on this Form 4 were made to 501(c)(3) charities, including the Make-A-Wish Foundation of America.
F2: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F3: This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $12.34 to $12.90 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.